Laurus Labs Limited — Updates, 24-10-2024: Press Release

Laurus Labs reported its Q2 and H1 FY25 financial results, with H1 revenues at ₹2,419 Cr, reflecting a 1% growth. Q2 revenues remained flat at ₹1,224 Cr, with EBITDA at ₹182 Cr and a margin of 14.9%. Gross margins improved to 55.2%. Key growth seen in the CDMO-Synthesis segment, increasing by 33% YoY. The company expects stronger performance in H2, driven by project deliveries and margin improvements while managing ongoing CAPEX investments.